These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23984822)

  • 1. Analysis of BRCA1 and mtDNA haplotypes and mtDNA polymorphism in familial breast cancer.
    Gutiérrez Povedano C; Salgado J; Gil C; Robles M; Patiño-García A; García-Foncillas J
    Mitochondrial DNA; 2015 Apr; 26(2):227-31. PubMed ID: 23984822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial DNA variants and risk of familial breast cancer: an exploratory study.
    Tommasi S; Favia P; Weigl S; Bianco A; Pilato B; Russo L; Paradiso A; Petruzzella V
    Int J Oncol; 2014 May; 44(5):1691-8. PubMed ID: 24603941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of single nucleotide polymorphisms and haplotypes in BRCA1 in breast cancer: Czech case-control study.
    Soucek P; Borovanova T; Pohlreich P; Kleibl Z; Novotny J
    Breast Cancer Res Treat; 2007 Jun; 103(2):219-24. PubMed ID: 17039264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A haplotype-based case-control study of BRCA1 and sporadic breast cancer risk.
    Freedman ML; Penney KL; Stram DO; Riley S; McKean-Cowdin R; Le Marchand L; Altshuler D; Haiman CA
    Cancer Res; 2005 Aug; 65(16):7516-22. PubMed ID: 16103107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial genome variations in advanced stage breast cancer: a case-control study.
    Tipirisetti NR; Lakshmi RK; Govatati S; Govatati S; Vuree S; Singh L; Raghunadha Rao D; Bhanoori M; Vishnupriya S
    Mitochondrion; 2013 Jul; 13(4):372-8. PubMed ID: 23628690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A BRCA1 promoter variant (rs11655505) and breast cancer risk.
    Verderio P; Pizzamiglio S; Southey MC; Spurdle AB; Hopper JL; Chen X; Beesley J; ; Schmutzler RK; Engel C; Burwinkel B; Bugert P; Ficarazzi F; Manoukian S; Barile M; Wappenschmidt B; Chenevix-Trench G; Radice P; Peterlongo P
    J Med Genet; 2010 Apr; 47(4):268-70. PubMed ID: 20413709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1.
    Bau DT; Fu YP; Chen ST; Cheng TC; Yu JC; Wu PE; Shen CY
    Cancer Res; 2004 Jul; 64(14):5013-9. PubMed ID: 15256476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial DNA Haplogroup K Is Protective Against Autism Spectrum Disorder Risk in Populations of European Ancestry.
    Chang X; Qu HQ; Liu Y; Glessner JT; Hakonarson H
    J Am Acad Child Adolesc Psychiatry; 2024 Aug; 63(8):835-844. PubMed ID: 38072244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mtDNA haplogroups and osteoarthritis in different geographic populations.
    Soto-Hermida A; Fernández-Moreno M; Oreiro N; Fernández-López C; Rego-Pérez I; Blanco FJ
    Mitochondrion; 2014 Mar; 15():18-23. PubMed ID: 24632472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced mitochondrial DNA copy number is associated with the haplogroup, and some clinical features of breast cancer in Mexican patients.
    Domínguez-de-la-Cruz E; Muñoz ML; Pérez-Muñoz A; García-Hernández N; Moctezuma-Meza C; Hinojosa-Cruz JC
    Gene; 2020 Nov; 761():145047. PubMed ID: 32783993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 655Val and 1170Pro ERBB2 SNPs in familial breast cancer risk and BRCA1 alterations.
    Tommasi S; Fedele V; Lacalamita R; Bruno M; Schittulli F; Ginzinger D; Scott G; Eppenberger-Castori S; Calistri D; Casadei S; Seymour I; Longo S; Giannelli G; Pilato B; Simone G; Benz CC; Paradiso A
    Cell Oncol; 2007; 29(3):241-8. PubMed ID: 17452776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy.
    Tommasi S; Crapolicchio A; Lacalamita R; Bruno M; Monaco A; Petroni S; Schittulli F; Longo S; Digennaro M; Calistri D; Mangia A; Paradiso A
    Mutat Res; 2005 Oct; 578(1-2):395-405. PubMed ID: 16026807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes.
    Sigurdson AJ; Hauptmann M; Chatterjee N; Alexander BH; Doody MM; Rutter JL; Struewing JP
    BMC Cancer; 2004 Mar; 4():9. PubMed ID: 15113441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The BRCA1 3'-UTR: 5711+421T/T_5711+1286T/T genotype is a possible breast and ovarian cancer risk factor.
    Pongsavee M; Yamkamon V; Dakeng S; O-charoenrat P; Smith DR; Saunders GF; Patmasiriwat P
    Genet Test Mol Biomarkers; 2009 Jun; 13(3):307-17. PubMed ID: 19405875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Mitochondrial DNA Haplogroup Variation and Autism Spectrum Disorders.
    Chalkia D; Singh LN; Leipzig J; Lvova M; Derbeneva O; Lakatos A; Hadley D; Hakonarson H; Wallace DC
    JAMA Psychiatry; 2017 Nov; 74(11):1161-1168. PubMed ID: 28832883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare BRCA1 haplotypes including 3'UTR SNPs associated with breast cancer risk.
    Pelletier C; Speed WC; Paranjape T; Keane K; Blitzblau R; Hollestelle A; Safavi K; van den Ouweland A; Zelterman D; Slack FJ; Kidd KK; Weidhaas JB
    Cell Cycle; 2011 Jan; 10(1):90-9. PubMed ID: 21191178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on familial breast cancer risk.
    Yang R; Chen B; Hemminki K; Wappenschmidt B; Engel C; Sutter C; Ditsch N; Weber BH; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B
    Breast Cancer Res Treat; 2009 Nov; 118(2):407-13. PubMed ID: 19229607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for XRCC4 in age at diagnosis and breast cancer risk.
    Allen-Brady K; Cannon-Albright LA; Neuhausen SL; Camp NJ
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1306-10. PubMed ID: 16835328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer susceptibility variants alter risks in familial disease.
    Latif A; Hadfield KD; Roberts SA; Shenton A; Lalloo F; Black GC; Howell A; Evans DG; Newman WG
    J Med Genet; 2010 Feb; 47(2):126-31. PubMed ID: 19617217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.